CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,010
-90 (-0.89%)
At close: Apr 2, 2025, 3:30 PM KST

CJ Bioscience Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-32,838-22,913-34,913-19,272-8,763
Upgrade
Depreciation & Amortization
4,3215,1463,9001,5621,051
Upgrade
Loss (Gain) From Sale of Assets
-10.89-8,718366.99-10.4389.96
Upgrade
Asset Writedown & Restructuring Costs
---170.67-
Upgrade
Stock-Based Compensation
-141.5543.83555.76133.93
Upgrade
Provision & Write-off of Bad Debts
---105.27-
Upgrade
Other Operating Activities
1,8461,8803,3759,460667.78
Upgrade
Change in Accounts Receivable
88.9142.18-70.3-191.24-3.25
Upgrade
Change in Inventory
29.07-81.6669.66-231.19-265.64
Upgrade
Change in Accounts Payable
98.01-213.8448.91-421.5420.07
Upgrade
Change in Unearned Revenue
28.67119.84211.4953.7131.82
Upgrade
Change in Other Net Operating Assets
-1,324-401.615,505-218.1-1,342
Upgrade
Operating Cash Flow
-27,760-24,899-20,963-8,437-7,978
Upgrade
Capital Expenditures
-377.59-4,924-4,145-952.65-12,018
Upgrade
Sale of Property, Plant & Equipment
26.3433,11685.0910.45-
Upgrade
Cash Acquisitions
---6,239--
Upgrade
Sale (Purchase) of Intangibles
-206.02-11,493-725.5-26.1-2.32
Upgrade
Investment in Securities
-67,0000.2118,0187,158-513.34
Upgrade
Other Investing Activities
--0171.58262.42-0
Upgrade
Investing Cash Flow
-67,55716,6997,1656,453-26,506
Upgrade
Short-Term Debt Issued
1,7051,3052,636--
Upgrade
Long-Term Debt Issued
----41,996
Upgrade
Total Debt Issued
1,7051,3052,636-41,996
Upgrade
Long-Term Debt Repaid
-1,864-23,077-1,414-22,768-476.63
Upgrade
Net Debt Issued (Repaid)
-159.04-21,7721,222-22,76841,519
Upgrade
Issuance of Common Stock
39,97044,9775073,479826.53
Upgrade
Other Financing Activities
-311.73-260.87-280.02-00
Upgrade
Financing Cash Flow
39,49922,944992.1850,71142,345
Upgrade
Foreign Exchange Rate Adjustments
32.1326.7469.6978.440.87
Upgrade
Miscellaneous Cash Flow Adjustments
000--
Upgrade
Net Cash Flow
-55,78614,772-12,73748,8057,901
Upgrade
Free Cash Flow
-28,138-29,823-25,108-9,390-19,997
Upgrade
Free Cash Flow Margin
-811.70%-534.93%-616.19%-215.22%-376.48%
Upgrade
Free Cash Flow Per Share
-3034.18-4210.56-4271.74-2208.24-5179.37
Upgrade
Cash Interest Paid
311.73190.8730.02361.12249.03
Upgrade
Cash Income Tax Paid
70.741.48141.565.331.88
Upgrade
Levered Free Cash Flow
-16,913-32,209-17,249-6,708-17,565
Upgrade
Unlevered Free Cash Flow
-16,546-31,633-15,522-3,603-16,551
Upgrade
Change in Net Working Capital
-1,117468.31-5,675-1,575394.69
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.